VivaQuant Receives FDA 510(k) Clearance for its RX-1 Rhythm ExpressTM Arrhythmia Device


ST. PAUL, Minn.–(BUSINESS WIRE)–lt;a href="" target="_blank"gt;#CardiacMonitorlt;/agt;–VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, has received FDA clearance for its RX-1 wearable device. RX-1 continuously monitors a patient’s ECG as they go about their normal daily activities, identifies arrhythmias, and communicates the information to the cloud using a built-in cellular connection. Skilled staff in a US-based monitoring center review the incoming data and re

- Advertisement -